Name: UMIN ID:
Unique ID issued by UMIN | UMIN000028170 |
---|---|
Receipt number | R000031754 |
Scientific Title | S-1 and CPT-11 plus ramucirumab (IRIS+Rmab) as second-line chemotherapy for patients with oxaliplatin-refractory metastatic colorectal cancer: A multicenter phase II study in Japan (N-DOCC-F-C-1701) |
Date of disclosure of the study information | 2017/07/19 |
Last modified on | 2019/04/29 14:48:57 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2017/07/10 21:48:06 | ||
2 | Update | 2017/07/18 15:35:36 | Date of disclosure of the study information |
|
3 | Update | 2018/07/02 16:28:43 | Results Results |
|
4 | Update | 2019/01/10 10:16:55 | Results Results |
|
5 | Update | 2019/04/29 14:31:28 | Number of participants that the trial has enrolled Results Results Results date posted |
|
6 | Update | 2019/04/29 14:48:57 | Recruitment status Date of IRB Last follow-up date Date of closure to data entry Date analysis concluded Other related information Other related information |